Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{d390c7938deb45a19db87253edd22977,
title = "Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome",
abstract = "Infective endocarditis (IE) is a life-threatening infective disease with increasing incidence worldwide. From early on, in the antibiotic era, it was recognized that high-dose and long-term antibiotic therapy was correlated to improved outcome. In addition, for several of the common microbial IE etiologies, the use of combination antibiotic therapy further improves outcome. IE vegetations on affected heart valves from patients and experimental animal models resemble biofilm infections. Besides the recalcitrant nature of IE, the microorganisms often present in an aggregated form, and gradients of bacterial activity in the vegetations can be observed. Even after appropriate antibiotic therapy, such microbial formations can often be identified in surgically removed, infected heart valves. Therefore, persistent or recurrent cases of IE, after apparent initial infection control, can be related to biofilm formation in the heart valve vegetations. On this background, the present review will describe potentially novel non-antibiotic, antimicrobial approaches in IE, with special focus on anti-thrombotic strategies and hyperbaric oxygen therapy targeting the biofilm formation of the infected heart valves caused by Staphylococcus aureus. The format is translational from preclinical models to actual clinical treatment strategies.",
keywords = "biofilm, dabigatran, hyperbaric oxygen therapy, in vitro, in vivo, infective endocarditis, innate immunity, Staphylococcus aureus",
author = "Lerche, {Christian Johann} and Franziska Schwartz and Marie Theut and Fosb{\o}l, {Emil Loldrup} and Kasper Iversen and Henning Bundgaard and Niels H{\o}iby and Claus Moser",
note = "Funding Information: CM was supported by the Novo Nordisk Foundation-“Borregaard Clinical Scientist Grant” (grant no. NNF17OC0025074). Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2021 Lerche, Schwartz, Theut, Fosb{\o}l, Iversen, Bundgaard, H{\o}iby and Moser. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = jun,
day = "18",
doi = "10.3389/fcell.2021.643335",
language = "English",
volume = "9",
journal = "Frontiers in Cell and Developmental Biology",
issn = "2296-634X",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome

AU - Lerche, Christian Johann

AU - Schwartz, Franziska

AU - Theut, Marie

AU - Fosbøl, Emil Loldrup

AU - Iversen, Kasper

AU - Bundgaard, Henning

AU - Høiby, Niels

AU - Moser, Claus

N1 - Funding Information: CM was supported by the Novo Nordisk Foundation-“Borregaard Clinical Scientist Grant” (grant no. NNF17OC0025074). Publisher Copyright: © Copyright © 2021 Lerche, Schwartz, Theut, Fosbøl, Iversen, Bundgaard, Høiby and Moser. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/6/18

Y1 - 2021/6/18

N2 - Infective endocarditis (IE) is a life-threatening infective disease with increasing incidence worldwide. From early on, in the antibiotic era, it was recognized that high-dose and long-term antibiotic therapy was correlated to improved outcome. In addition, for several of the common microbial IE etiologies, the use of combination antibiotic therapy further improves outcome. IE vegetations on affected heart valves from patients and experimental animal models resemble biofilm infections. Besides the recalcitrant nature of IE, the microorganisms often present in an aggregated form, and gradients of bacterial activity in the vegetations can be observed. Even after appropriate antibiotic therapy, such microbial formations can often be identified in surgically removed, infected heart valves. Therefore, persistent or recurrent cases of IE, after apparent initial infection control, can be related to biofilm formation in the heart valve vegetations. On this background, the present review will describe potentially novel non-antibiotic, antimicrobial approaches in IE, with special focus on anti-thrombotic strategies and hyperbaric oxygen therapy targeting the biofilm formation of the infected heart valves caused by Staphylococcus aureus. The format is translational from preclinical models to actual clinical treatment strategies.

AB - Infective endocarditis (IE) is a life-threatening infective disease with increasing incidence worldwide. From early on, in the antibiotic era, it was recognized that high-dose and long-term antibiotic therapy was correlated to improved outcome. In addition, for several of the common microbial IE etiologies, the use of combination antibiotic therapy further improves outcome. IE vegetations on affected heart valves from patients and experimental animal models resemble biofilm infections. Besides the recalcitrant nature of IE, the microorganisms often present in an aggregated form, and gradients of bacterial activity in the vegetations can be observed. Even after appropriate antibiotic therapy, such microbial formations can often be identified in surgically removed, infected heart valves. Therefore, persistent or recurrent cases of IE, after apparent initial infection control, can be related to biofilm formation in the heart valve vegetations. On this background, the present review will describe potentially novel non-antibiotic, antimicrobial approaches in IE, with special focus on anti-thrombotic strategies and hyperbaric oxygen therapy targeting the biofilm formation of the infected heart valves caused by Staphylococcus aureus. The format is translational from preclinical models to actual clinical treatment strategies.

KW - biofilm

KW - dabigatran

KW - hyperbaric oxygen therapy

KW - in vitro

KW - in vivo

KW - infective endocarditis

KW - innate immunity

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=85109103402&partnerID=8YFLogxK

U2 - 10.3389/fcell.2021.643335

DO - 10.3389/fcell.2021.643335

M3 - Review

C2 - 34222225

AN - SCOPUS:85109103402

VL - 9

JO - Frontiers in Cell and Developmental Biology

JF - Frontiers in Cell and Developmental Biology

SN - 2296-634X

M1 - 643335

ER -

ID: 66724800